Product category:
Clinical chemistry analysis
News Release from: Molecular Devices
Edited by the Laboratorytalk Editorial
Team on 18 April 2002
Molecular Devices appoints general
manager Europe
Steve Davenport, a 13-year veteran of Amersham Biosciences, takes on role of general manager of European operations for drug discovery and life sciences firm
Molecular Devices has announced the appointment of Steve Davenport to the role of general manager, European operations Davenport joins Molecular Devices from Amersham Biosciences where he worked for 13 years, holding a number of positions including co-ordinating sales of innovative new technologies for drug discovery to pharmaceutical and biotechnology companies and major academic institutes throughout Europe
This article was originally published on Laboratorytalk on 13 Jun 2008 at 8.00am (UK)
Related stories
MDS introduces new systems for genomics research
New Axon GenePix microarray scanners and Arcturus laser capture microdissection instrument improve research speed and precision
He has gained extensive experience in the areas of genomics, proteomics, cell biology, and high throughput screening, working with teams in UK, Scandinavia, Benelux, France, Switzerland, Italy and Spain.
Stephen Oldfield, vice president of worldwide marketing at Molecular Devices, commented "During the last decade Molecular Devices has seen huge growth, especially in Europe, we hope that with Steve we will see this growth continue into the next decade.
Steve brings with him a proven commercial and European track record, we are pleased to welcome him to the Molecular Devices team". Request free introductory details about products from Molecular Devices ...
• Molecular Devices: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
